Abstract
To evaluate the relationship between Chlamydia pneumoniae infection and lung cancer, we conducted a metaanalysis of studies comparing the antibodies of C. pneumoniae between lung cancer patients and controls. The random-effects model or fixed-effects model was used according to the results of heterogeneity tests. Total, 8 studies with 1602 cases and 1734 controls were included. The analysis showed that the pooled OR of the association between C. pneumoniae IgA and lung cancer was 1.82 (95% CI, 1.21-2.74), while the association between C. pneumoniae IgG and lung cancer was 1.77 (95% CI, 1.13-2.78). Thus, statistically significant differences were observed between C. pneumoniae antibodies and lung cancer. This meta-analysis suggests that C. pneumoniae infection may be a potential risk factor for lung cancer.
Keywords: Chlamydia pneumoniae, lung cancer, meta-analysis
Current Respiratory Medicine Reviews
Title: Association Between Chlamydia pneumoniae Antibodies and Lung Cancer: A Meta-Analysis
Volume: 6 Issue: 3
Author(s): Zhuang Liu, Zhi-hua Yin, Hui-ying Liang, Zhi-fang Jia and Bao-sen Zhou
Affiliation:
Keywords: Chlamydia pneumoniae, lung cancer, meta-analysis
Abstract: To evaluate the relationship between Chlamydia pneumoniae infection and lung cancer, we conducted a metaanalysis of studies comparing the antibodies of C. pneumoniae between lung cancer patients and controls. The random-effects model or fixed-effects model was used according to the results of heterogeneity tests. Total, 8 studies with 1602 cases and 1734 controls were included. The analysis showed that the pooled OR of the association between C. pneumoniae IgA and lung cancer was 1.82 (95% CI, 1.21-2.74), while the association between C. pneumoniae IgG and lung cancer was 1.77 (95% CI, 1.13-2.78). Thus, statistically significant differences were observed between C. pneumoniae antibodies and lung cancer. This meta-analysis suggests that C. pneumoniae infection may be a potential risk factor for lung cancer.
Export Options
About this article
Cite this article as:
Liu Zhuang, Yin Zhi-hua, Liang Hui-ying, Jia Zhi-fang and Zhou Bao-sen, Association Between Chlamydia pneumoniae Antibodies and Lung Cancer: A Meta-Analysis, Current Respiratory Medicine Reviews 2010; 6 (3) . https://dx.doi.org/10.2174/157339810791526111
DOI https://dx.doi.org/10.2174/157339810791526111 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Angiogenesis as a Therapeutic Target in Arthritis: Lessons from Oncology
Current Pharmaceutical Design Drug Treatment of Obesity: Established and Emerging Therapies
Mini-Reviews in Medicinal Chemistry Bioinformatics Analysis Reveals Centromere Protein K Can Serve as Potential Prognostic Biomarker and Therapeutic Target for Non-small Cell Lung Cancer
Current Bioinformatics Insulin-like Growth Factor: Current Concepts and New Developments in Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Determination of Usnic Acid Responsive miRNAs in Breast Cancer Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Subject Index To Volume 6
Current Molecular Medicine Bisacylimidoselenocarbamates Cause G2/M Arrest Associated with the Modulation of CDK1 and Chk2 in Human Breast Cancer MCF-7 Cells
Current Medicinal Chemistry Lung Cancer and Radiological Imaging
Current Radiopharmaceuticals RETRACTED: Aberrant Sialylation in Cancer Pathology and Metastasis, a Putative Drug Target Candidate
Anti-Cancer Agents in Medicinal Chemistry Novel Oncogenic Protein Kinase Inhibitors for Cancer Therapy
Current Medicinal Chemistry - Anti-Cancer Agents Nicotine, Lung and Cancer
Anti-Cancer Agents in Medicinal Chemistry Erlotinib in Non-Small Cell Lung Cancer: From a thought to Necessity
Clinical Cancer Drugs The Quest for a Tumor Suppressor Gene Phenotype
Current Molecular Medicine Cytostatic and Cytotoxic Activity of Synthetic Diterpene Derivatives Obtained from (-)-Kaur-9(11), 16-Dien-19-Oic Acid Against Human Cancer Cell Lines
Letters in Drug Design & Discovery Exploration of the Medicinal Peptide Space
Protein & Peptide Letters Functional Domains of Aquaporin-1: Keys to Physiology, and Targets for Drug Discovery
Current Pharmaceutical Design MRP4/ABCC4 As a New Therapeutic Target: Meta-Analysis to Determine cAMP Binding Sites as a Tool for Drug Design
Current Medicinal Chemistry Chitosan Anchored Nanoparticles in Current Drug Development Utilizing Computer-Aided Pharmacokinetic Modeling: Case Studies for Target Specific Cancer Treatment and Future Prospective
Current Pharmaceutical Design Identification of Key mRNAs, miRNAs, and mRNA-miRNA Network Involved in Papillary Thyroid Carcinoma
Current Bioinformatics The Role of Chemotherapy and Radiation in the Treatment of Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
Current Drug Targets